Urol. praxi, 2012; 13(2): 85-87

Role of magnetic resonance spectroscopy in indicating prostate rebiopsy

MUDr.Markéta Matějková1, MUDr.Jaromír Frydrych2, MUDr.Jaroslav Všetička, Ph.D.1
1 Urologické oddělení nemocnice Jablonec nad Nisou
2 Radiodiagnostické oddělení nemocnice Jablonec nad Nisou

The prostate needle biopsy has become the procedure of choice for obtaining tissue cores for histopatological investigation in patients

with prostate cancer suspicion. In case of negative results, second prostate needle biopsy is indicated. This procedure is not very well

perceived by patients as they might feel discomfort. Prostate magnetic resonance spectroscopy imaging brings us new option of prostate

cancer detection in patients, where the first biopsy was proved negative. We would like to present our two-year old results having

used the MRS mentioned above.

Keywords: magnetic resonance imaging, spectroscopy, prostate biopsy

Published: March 16, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějková M, Frydrych J, Všetička J. Role of magnetic resonance spectroscopy in indicating prostate rebiopsy. Urol. praxi. 2012;13(2):85-87.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barnes AS, Haker SJ, Mulkern RV, So M, D'Amico AV, Tempany CM. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer, Urology 2005; 66(6): 1319, e13-1319, e15. Go to original source... Go to PubMed...
    2. Bárta J, Ryznarová Z, Klézl P, Záťura P, Adamová M, Kašpar M, Novák J. Postavení magnetické rezonance a magnetické rezonanční spektroskopie při detekci karcinomu prostaty, Ces. Urol. 2010; 14(3): 186-195.
    3. Bonekamp D, Jacobs MA, El-Khouli R, Stoianovici D, Macura KJ. Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions, RadioGraphics, 2011; 31: 677-704. Go to original source... Go to PubMed...
    4. Kim ChK, Park BK, Kim B. Diffusion-Weighted MRI at 3 T for the Evaluation of Prostate Cancor, AJR: 194, June 2010: 1461-1469. Go to original source... Go to PubMed...
    5. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy, Urology, 45, Issue 3, March 1995: 459-466. Go to original source... Go to PubMed...
    6. Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TWJ, Pang Y, Choule PL. Prostate MRI and 3D MR Spectroscopy: How We Do It, AJR 2010; 194: 1414-1426. Go to original source... Go to PubMed...
    7. Nogueira L, Wang L, Fine SW, Pinochet R, Kurta JM, Katz D, Savage CJ, Bronin AM, Hricak H, Sardino PT, Akin O, Coleman JA. Focal Treatment or Observation of Prostate Cancer: Pretreatment Accuracy of Transrectal Ultrasound Biopsy and T2-weighted MRI, Urology 2010; 75(2): 472-477. Go to original source... Go to PubMed...
    8. http://www.uroweb.cz/index.php?pg=dg-nadory-prostaty-epidemiologie-ceska-republika-vyvoj-incidencemortalita.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.